The BD Veritor System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.
The system has an unique adaptive read technology – helps reduce false-positive results by examining the sample and compensating for many of the effects of non-specific binding to help deliver a more accurate read. Eliminates the need for visual-read and subjective interpretation by providing objective results on an easy-to-read digital display. Delivers results in minutes.
Veritor™ System for Rapid Detection of SARS-CoV-2, 30 tests/kit (12 kt/cs; 28 cs/plt) (Short-Dated, Minimum Expiry Lead is 30 days; Non-cancellable; Non-returnable; Non-refundable) (Continental US Only)
